These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33633041)

  • 1. Emerging therapy in light-chain and acquired transthyretin-related amyloidosis: an Italian single-centre experience in heart transplantation.
    Di Nora C; Sponga S; Ferrara V; Patriarca F; Fanin R; Nalli C; Lechiancole A; Vendramin I; Livi U
    J Cardiovasc Med (Hagerstown); 2021 Apr; 22(4):261-267. PubMed ID: 33633041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac Amyloidosis Treatment.
    Stern LK; Patel J
    Methodist Debakey Cardiovasc J; 2022; 18(2):59-72. PubMed ID: 35414852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac amyloidosis: updates in diagnosis and management.
    Mohty D; Damy T; Cosnay P; Echahidi N; Casset-Senon D; Virot P; Jaccard A
    Arch Cardiovasc Dis; 2013 Oct; 106(10):528-40. PubMed ID: 24070600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.
    Rubin J; Maurer MS
    Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermediate-term outcomes of heart transplantation for cardiac amyloidosis in the current era.
    Vaidya GN; Patel JK; Kittleson M; Chang DH; Kransdorf E; Geft D; Czer L; Vescio R; Esmailian F; Kobashigawa JA
    Clin Transplant; 2021 Jun; 35(6):e14308. PubMed ID: 33825224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment options for severe cardiac amyloidosis: heart transplantation combined with chemotherapy and stem cell transplantation for patients with AL-amyloidosis and heart and liver transplantation for patients with ATTR-amyloidosis.
    Sack FU; Kristen A; Goldschmidt H; Schnabel PA; Dengler T; Koch A; Karck M
    Eur J Cardiothorac Surg; 2008 Feb; 33(2):257-62. PubMed ID: 18096396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac transplantation followed by dose-intensive melphalan and autologous stem-cell transplantation for light chain amyloidosis and heart failure.
    Dey BR; Chung SS; Spitzer TR; Zheng H; Macgillivray TE; Seldin DC; McAfee S; Ballen K; Attar E; Wang T; Shin J; Newton-Cheh C; Moore S; Sanchorawala V; Skinner M; Madsen JC; Semigran MJ
    Transplantation; 2010 Oct; 90(8):905-11. PubMed ID: 20733534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of heart transplantation for cardiac amyloidosis: subanalysis of the spanish registry for heart transplantation.
    Roig E; Almenar L; González-Vílchez F; Rábago G; Delgado J; Gómez-Bueno M; Crespo-Leiro MG; Arizón JM; de la Fuente L; Manito N;
    Am J Transplant; 2009 Jun; 9(6):1414-9. PubMed ID: 19459811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed autologous stem cell transplantation following cardiac transplantation experience in patients with cardiac amyloidosis.
    Trachtenberg BH; Kamble RT; Rice L; Araujo-Gutierrez R; Bhimaraj A; Guha A; Park MH; Hussain I; Bruckner BA; Suarez EE; Victor DW; Adrogue HE; Baker KR; Estep JD
    Am J Transplant; 2019 Oct; 19(10):2900-2909. PubMed ID: 31152491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Good long-term survival after paediatric heart transplantation.
    Kruse CD; Helvind M; Jensen T; Gustafsson F; Mortensen SA; Andersen HO
    Dan Med J; 2012 Jan; 59(1):A4367. PubMed ID: 22239842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Misconceptions and Facts About Cardiac Amyloidosis.
    Nguyen FD; Rodriguez M; Krittanawong C; Witteles R; Lenihan DJ
    Am J Cardiol; 2021 Dec; 160():99-105. PubMed ID: 34610875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment With Bortezomib-based Therapy, Followed by Autologous Stem Cell Transplantation, Improves Outcomes in Light Chain Amyloidosis: A Retrospective Study.
    Jain T; Kosiorek HE; Kung ST; Shah VS; Dueck AC; Gonzalez-Calle V; Luft S; Reeder CB; Adams R; Noel P; Larsen JT; Mikhael J; Bergsagel L; Stewart AK; Fonseca R
    Clin Lymphoma Myeloma Leuk; 2018 Jul; 18(7):486-492.e1. PubMed ID: 29753692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress and challenges in the treatment of cardiac amyloidosis: a review of the literature.
    Adam RD; Coriu D; Jercan A; Bădeliţă S; Popescu BA; Damy T; Jurcuţ R
    ESC Heart Fail; 2021 Aug; 8(4):2380-2396. PubMed ID: 34089308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline ECG Features and Arrhythmic Profile in Transthyretin Versus Light Chain Cardiac Amyloidosis.
    Cappelli F; Vignini E; Martone R; Perlini S; Mussinelli R; Sabena A; Morini S; Gabriele M; Taborchi G; Bartolini S; Lossi A; Nardi G; Marchionni N; Di Mario C; Olivotto I; Perfetto F
    Circ Heart Fail; 2020 Mar; 13(3):e006619. PubMed ID: 32164434
    [No Abstract]   [Full Text] [Related]  

  • 15. Emerging Advances in the Management of Cardiac Amyloidosis.
    Vranian MN; Sperry BW; Valent J; Hanna M
    Curr Cardiol Rep; 2015 Nov; 17(11):100. PubMed ID: 26374453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropathy Associated with Systemic Amyloidosis.
    Kaku M; Berk JL
    Semin Neurol; 2019 Oct; 39(5):578-588. PubMed ID: 31639841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac amyloidosis: pathogenesis, clinical context, diagnosis and management options.
    Alkhawam H; Patel D; Nguyen J; Easaw SM; Al-Sadawi M; Syed U; Zaiem F; Homsi M; Vittorio TJ
    Acta Cardiol; 2017 Aug; 72(4):380-389. PubMed ID: 28705053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous Stem Cell Transplant for IgM-Associated Amyloid Light-Chain Amyloidosis.
    Sidiqi MH; Buadi FK; Dispenzieri A; Warsame R; Lacy MQ; Dingli D; Leung N; Gonsalves WI; Kapoor P; Kourelis TV; Hogan WJ; Kumar SK; Gertz MA
    Biol Blood Marrow Transplant; 2019 Mar; 25(3):e108-e111. PubMed ID: 30529461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous stem cell transplantation vs bortezomib based chemotheraphy for the first-line treatment of systemic light chain amyloidosis in the UK.
    Sharpley FA; Manwani R; Petrie A; Mahmood S; Sachchithanantham S; Lachmann HJ; Martinez De Azcona Naharro A; Gillmore JD; Whelan CJ; Fontana M; Cohen O; Hawkins PN; Wechalekar AD
    Eur J Haematol; 2021 Apr; 106(4):537-545. PubMed ID: 33460466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Heart transplantation in AL amyloidosis].
    Dahlberg P; Bartfay SE; Karason K; Mellqvist UH; Bollano E
    Lakartidningen; 2018 Mar; 115():. PubMed ID: 29583159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.